SS Innovations International Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
45.0%projected annual EPS growth
Analyst Coverage
1analyst covering
FY Revenue (est.)
$59.4Mnext fiscal year
FY EPS (est.)
-$0.06next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Quarterly Report (Form 10-Q) | 16 Nov 2026 |
| FY 2026 Annual Report (Form 10-K) | 15 Mar 2027 |
Monitoring Framework
Key Performance Indicators
SSi Mantra Cumulative Installed Base Quarterly194.0
SSi Mantra Cumulative Surgeries Quarterly9.7K
Quarterly Revenue (USD) Quarterly11.1M
Gross Margin Quarterly48.0%
Watch Items
- U.S. FDA 510(k) Premarket Notification ApprovalTrigger: Official clearance notification from the FDAAction: Initiate commercial launch and marketing activities in the United States
- European Union CE Marking CertificationTrigger: Official CE Mark certification from Szutest (EU Notified Body)Action: Begin commercial distribution and sales operations across EU member states
- Cash Burn and Liquidity RunwayTrigger: Cash and cash equivalents falling below $5.0 millionAction: Evaluate additional capital raising options, including the $150 million shelf offering, or implement cost-containment measures
Research as of 19 Jun 2026